|
Index of reports
> Serious Reactions (965)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carboplatin serious reactions. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 965 Next >>
Possible Carboplatin side effects in male
Reported by a physician from United Kingdom on 2012-08-27
Patient: male, weighing 77.5 kg (170.5 pounds)
Reactions: Supraventricular Tachycardia
Drug(s) suspected as cause:
Carboplatin
Dosage: 300 mg, 30 min iv infusion, on day 1 of each 21 day cycle
Indication: Transitional Cell Carcinoma
Start date: 2012-06-22
End date: 2012-07-11
Gemcitabine Hydrochloride
Dosage: 1900 mg, 30 min iv infusion, on day 1 and 8 of each 21 day cycle
Indication: Transitional Cell Carcinoma
Start date: 2012-06-22
End date: 2012-07-19
Zd6474
Administration route: Oral
Indication: Transitional Cell Carcinoma
Start date: 2012-06-22
End date: 2012-08-01
Other drugs received by patient: Lactulose; Tinzaparin; Acetaminophen and Codeine Phosphate; Acetaminophen and Codeine Phosphate
Possible Carboplatin side effects in
Reported by a physician from Netherlands on 2012-08-27
Patient:
Reactions: Disease Progression
Drug(s) suspected as cause:
Avastin
Indication: non-Small Cell Lung Cancer
Carboplatin
Indication: non-Small Cell Lung Cancer
Pemetrexed
Indication: non-Small Cell Lung Cancer
Possible Carboplatin side effects in 72 year old female
Reported by a physician from United States on 2012-08-27
Patient: 72 year old female, weighing 71.6 kg (157.5 pounds)
Reactions: Ventricular Arrhythmia
Drug(s) suspected as cause:
Avastin
Dosage: 15 mg/kg iv over 30-90 minutes on day 1 on 2 cycle onwards
Indication: Ovarian Epithelial Cancer
Carboplatin
Dosage: auc 6 (cycle 1-6),6th cycle completed on 16/feb/2012
Indication: Ovarian Epithelial Cancer
Start date: 2011-11-23
Ipratropium Bromide
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 175 mg/m2 over 3 hrs on day 1(cycle 1-6), 6th cycle completed on 16/feb/2012
Indication: Ovarian Epithelial Cancer
Start date: 2011-11-23
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Cyclophosphamide
Indication: Retinoblastoma
Doxorubicin Hydrochloride
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Etoposide
Indication: Retinoblastoma
Vincristine
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Other drugs received by patient: Neupogen
Possible Carboplatin side effects in female
Reported by a pharmacist from United States on 2012-08-24
Patient: female, weighing 139.7 kg (307.3 pounds)
Reactions: Glossodynia, Unresponsive To Stimuli, Hypoxia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Carboplatin
Other drugs received by patient: Lorazepam; Warfarin Sodium; Nifedipine; Citalopram Hydrobromide; Fiornal; Joint Food; Tylox; Losartan Potassium; Omeprazole; Paclitaxel; Calcium D3; Dexamethasone
Possible Carboplatin side effects in male
Reported by a physician from France on 2012-08-24
Patient: male
Reactions: Dermatitis Acneiform, Renal Failure, Neoplasm Malignant, Dehydration, Purpura, Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Dosage: 200 df, unknown/d
Indication: non-Small Cell Lung Cancer
Start date: 2012-08-03
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Start date: 2012-08-17
Pemetrexed Disodium
Dosage: 200 df, unknown/d
Indication: non-Small Cell Lung Cancer
Start date: 2012-08-03
Possible Carboplatin side effects in 58 year old male
Reported by a consumer/non-health professional from Argentina on 2012-08-24
Patient: 58 year old male
Reactions: Hepatotoxicity, Neoplasm Malignant, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Start date: 2012-01-01
Yervoy
Dosage: no of inf:2 infusion on 9feb12
Indication: Metastatic Malignant Melanoma
Start date: 2012-02-09
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: , weighing 1.9 kg (4.1 pounds)
Reactions: Foetal Growth Restriction, Foetal Exposure During Pregnancy
Drug(s) suspected as cause:
Carboplatin
Indication: Ovarian Cancer Stage I
Paclitaxel
Indication: Ovarian Cancer Stage I
Possible Carboplatin side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22
Patient: 62 year old female
Reactions: Appendicitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 1df: 4auc on day 1 of each 21 day cycle
Indication: Neoplasm
Start date: 2012-03-21
Gemcitabine Hydrochloride
Dosage: 12jun12 end of cycle 4, day 1 and 8 of each 21 day cycle
Indication: Neoplasm
Start date: 2012-04-11
Other drugs received by patient: Alprazolam; Sodium Chloride; Dexamethasone; Acetaminophen; Ondansetron; Pegfilgrastim; Prochlorperazine Edisylate; Aprepitant; Omega 3 Fatty Acid; Ergocalciferol; Esomeprazole Sodium; Docusate Sodium; Hydrocortisone; Lorazepam; Acetaminophen; Pepcid; Aprepitant; Heparin; Benadryl; Prochlorperazine Edisylate; Hydrocortisone Sodium Succinate; Multi-Vitamin; Levothyroxine Sodium; Omeprazole; Pegfilgrastim
Possible Carboplatin side effects in
Reported by a consumer/non-health professional from Singapore on 2012-08-22
Patient:
Reactions: Incorrect Route of Drug Administration, Myalgia, Tumour Lysis Syndrome, Rhabdomyolysis, Demyelination
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Etoposide
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Ifosfamide
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Rituximab
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Velcade
Dosage: unk mg/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Velcade
Dosage: unk
Start date: 2012-07-31
Other drugs received by patient: Methotrexate; Lamivudine; Acyclovir; Pentamidine; Omeprazole
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22
Patient:
Reactions: Off Label Use, Gastrointestinal Toxicity
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Cyclophosphamide
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Doxorubicin HCL
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Etoposide
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Vincristine
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Other drugs received by patient: Neupogen
Possible Carboplatin side effects in female
Reported by a physician from Germany on 2012-08-22
Patient: female, weighing 89.0 kg (195.8 pounds)
Reactions: Alanine Aminotransferase Increased, Liver Disorder
Drug(s) suspected as cause:
Carboplatin
Indication: Breast Cancer
Start date: 2012-06-04
End date: 2012-07-02
Lapatinib
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-04
End date: 2012-06-21
Npld (Non-Pegylated Liposomal Doxorubicin)
Indication: Breast Cancer
Start date: 2012-06-04
End date: 2012-07-23
Paclitaxel
Indication: Breast Cancer
Start date: 2012-06-04
End date: 2012-07-23
Trastuzumab
Indication: Breast Cancer
Start date: 2012-06-04
End date: 2012-07-02
Other drugs received by patient: Fraxiparina
Possible Carboplatin side effects in 14 month old male
Reported by a physician from United States on 2012-08-21
Patient: 14 month old male
Reactions: Iris Neovascularisation, Retinal Artery Occlusion
Drug(s) suspected as cause:
Carboplatin
Dosage: 30 mg, unknown
Indication: Retinoblastoma Unilateral
Melphalan Hydrochloride
Dosage: 5 mg, unknown
Indication: Retinoblastoma Unilateral
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female
Reactions: LIP and / or Oral Cavity Cancer
Drug(s) suspected as cause:
Carboplatin
Dosage: completed 6 cycles
Indication: Ovarian Cancer Recurrent
Doxorubicin Hydrochloride
Dosage: after 6 cycles induction, maintained on doxorubicin for approximately 11 years
Indication: Ovarian Cancer Recurrent
Paclitaxel
Dosage: completed 6 cycles
Indication: Ovarian Cancer Recurrent
Topotecan Hydrochloride
Dosage: completed 6 cycles
Indication: Ovarian Cancer Recurrent
Possible Carboplatin side effects in
Reported by a physician from United States on 2012-08-21
Patient:
Reactions: Retinal Artery Occlusion
Drug(s) suspected as cause:
Carboplatin
Dosage: 30 mg, unknown
Indication: Retinoblastoma Unilateral
Melphalan Hydrochloride
Dosage: 5 mg, unknown
Indication: Retinoblastoma Unilateral
Possible Carboplatin side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient: 44 year old female
Reactions: Squamous Cell Carcinoma, Carbohydrate Antigen 125 Increased, Thrombocytopenia
Drug(s) suspected as cause:
ABT-888
Administration route: Oral
Indication: Ovarian Cancer
Start date: 2010-06-01
End date: 2011-04-01
Carboplatin
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2007-07-13
End date: 2007-09-14
Cisplatin
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2005-06-14
End date: 2005-08-10
Cyclophosphamide
Indication: Ovarian Cancer
Start date: 2010-06-01
End date: 2011-04-01
Doxorubicin Hydrochloride
Dosage: maintenance dose for a total cumulative dose of 1.696 mg
Indication: Ovarian Cancer
End date: 2010-04-01
Doxorubicin Hydrochloride
Dosage: 3 cycles given
Start date: 2007-07-13
End date: 2007-09-14
Paclitaxel
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2007-07-13
End date: 2007-09-14
Topotecan Hydrochloride
Start date: 2005-08-29
Topotecan Hydrochloride
Dosage: for 4 cycles
Indication: Ovarian Cancer
Start date: 2005-06-14
End date: 2005-08-02
Possible Carboplatin side effects in
Reported by a physician from United States on 2012-08-21
Patient:
Reactions: Poor Peripheral Circulation, Choroidal Dystrophy
Drug(s) suspected as cause:
Carboplatin
Dosage: 30 mg, unknown
Indication: Retinoblastoma Unilateral
Melphalan Hydrochloride
Dosage: 5 mg, unknown
Indication: Retinoblastoma Unilateral
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient:
Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Cyclophosphamide
Indication: Retinoblastoma
Doxorubicin HCL
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Etoposide
Indication: Retinoblastoma
Vincristine
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Other drugs received by patient: Neupogen
Possible Carboplatin side effects in 71 year old female
Reported by a physician from United States on 2012-08-21
Patient: 71 year old female
Reactions: Tongue Neoplasm Malignant Stage Unspecified
Drug(s) suspected as cause:
Carboplatin
Dosage: four cycles
Indication: Ovarian Cancer Recurrent
Start date: 2006-01-01
End date: 2006-01-01
Cisplatin
Indication: Ovarian Cancer
Doxorubicin Hydrochloride
Indication: Ovarian Cancer Recurrent
Start date: 2006-05-01
Doxorubicin Hydrochloride
Dosage: four cycles
Start date: 2006-01-01
End date: 2006-01-01
Paclitaxel
Indication: Ovarian Cancer
Possible Carboplatin side effects in female
Reported by a physician from Germany on 2012-08-20
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Fatigue, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bevacizumab
Indication: Breast Cancer
Start date: 2012-05-18
End date: 2012-08-09
Carboplatin
Indication: Breast Cancer
Start date: 2012-05-18
End date: 2012-08-09
Doxorubicin HCL
Indication: Breast Cancer
Start date: 2012-05-18
End date: 2012-08-09
Paclitaxel
Indication: Breast Cancer
Start date: 2012-05-18
End date: 2012-08-09
Possible Carboplatin side effects in female
Reported by a pharmacist from United States on 2012-08-20
Patient: female
Reactions: Glossodynia, Unresponsive To Stimuli
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient:
Reactions: Chorioretinal Atrophy
Drug(s) suspected as cause:
Carboplatin
Indication: Retinoblastoma
Melphalan Hydrochloride
Indication: Retinoblastoma
Possible Carboplatin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient:
Reactions: Retinal Artery Occlusion
Drug(s) suspected as cause:
Carboplatin
Indication: Retinoblastoma
Melphalan Hydrochloride
Indication: Retinoblastoma
Possible Carboplatin side effects in 14 month old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: 14 month old male
Reactions: Vascular Occlusion, Vitreous Haemorrhage, Iris Neovascularisation
Drug(s) suspected as cause:
Carboplatin
Indication: Retinoblastoma
Melphalan Hydrochloride
Indication: Retinoblastoma
Possible Carboplatin side effects in male
Reported by a physician from United Kingdom on 2012-08-15
Patient: male, weighing 77.5 kg (170.5 pounds)
Reactions: Supraventricular Tachycardia
Drug(s) suspected as cause:
Carboplatin
Dosage: 300 mg, 30 min iv infusion, on day 1 of each 21 day cycle
Indication: Transitional Cell Carcinoma
Start date: 2012-06-22
End date: 2012-07-11
Gemcitabine Hydrochloride
Dosage: 1900 mg, 30 min iv infusion, on day 1 and 8 of each 21 day cycle
Indication: Transitional Cell Carcinoma
Start date: 2012-06-22
End date: 2012-07-19
Zd6474
Administration route: Oral
Indication: Transitional Cell Carcinoma
Start date: 2012-06-22
End date: 2012-08-01
Other drugs received by patient: Acetaminophen and Codeine Phosphate; Acetaminophen and Codeine Phosphate; Lactulose
Possible Carboplatin side effects in 63 year old female
Reported by a consumer/non-health professional from Israel on 2012-08-15
Patient: 63 year old female
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
Carboplatin
Dosage: 100mg per m2
Start date: 2012-06-14
End date: 2012-06-24
Erbitux
Dosage: total :890mg 5mg/ml is the strength last infu:19jun12
Indication: Squamous Cell Carcinoma of THE Cervix
Start date: 2012-06-19
End date: 2012-06-24
Taxol
Dosage: 50mg per m2
Start date: 2012-06-14
End date: 2012-06-24
Possible Carboplatin side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-14
Patient: 72 year old male
Reactions: Pneumonia, Hypotension, Febrile Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Carboplatin
Dosage: 300 mg/m2 on day1
Indication: Small Cell Lung Cancer Stage Unspecified
Etoposide
Dosage: 50 mg/m2 on day1 and 3
Indication: Small Cell Lung Cancer Stage Unspecified
Possible Carboplatin side effects in 58 year old female
Reported by a physician from United States on 2012-08-13
Patient: 58 year old female, weighing 79.0 kg (173.8 pounds)
Reactions: Obstruction Gastric, Vomiting, Hyperkalaemia, Nausea, Supraventricular Tachycardia, Febrile Neutropenia, Aspiration, Sepsis, Abdominal Distension, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: last dose administered on 12/may/2011
Indication: Endometrial Cancer
Start date: 2012-05-12
Carboplatin
Dosage: auc=6; last dose administered on:12/may/2011
Indication: Endometrial Cancer
Start date: 2011-05-12
Ixabepilone
Dosage: last dose administerd:12/may/2011
Indication: Endometrial Cancer
Start date: 2012-05-12
Other drugs received by patient: Protonix; Norco; Compazine; Synthroid; Ventolin; Lovenox
Possible Carboplatin side effects in 70 year old female
Reported by a consumer/non-health professional from United States on 2012-08-13
Patient: 70 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Incorrect Dose Administered
Drug(s) suspected as cause:
Carboplatin
Dosage: 1 df = auc6:patient received 752 mg last dose 25oct11
Indication: non-Small Cell Lung Cancer
Start date: 2011-08-02
Pemetrexed Disodium
Dosage: last dose 25oct11
Indication: non-Small Cell Lung Cancer
Start date: 2011-08-02
Ramucirumab
Dosage: last dose 25oct11
Indication: non-Small Cell Lung Cancer
Start date: 2011-08-02
Other drugs received by patient: Morphine; Nortriptyline; Compazine; Crestor; Vitamin B-12; Nitroglycerin; Senokot; Folic Acid; Dexamethasone; Levothyroxine Sodium; MS Contin
Possible Carboplatin side effects in
Reported by a consumer/non-health professional from Singapore on 2012-08-13
Patient:
Reactions: Myalgia, Incorrect Route of Drug Administration, Rhabdomyolysis, Tumour Lysis Syndrome, Demyelination
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Etoposide
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Ifosfamide
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Rituximab
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Velcade
Dosage: unk mg/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Velcade
Dosage: unk
Start date: 2012-07-31
Other drugs received by patient: Methotrexate Sodium; Acyclovir; Pentamidine; Omeprazole; Lamivudine
Page 1 Next >>
|
